Answers are grounded in this paper and cite their sources.
Intravenous immunoglobulin (IVIG) is a blood derivative that is being evaluated for the prevention and treatment of numerous disorders. Recent studies have suggested beneficial effects from the prophylactic administration of IVIG to very-low-birth-weight neonates. A disadvantage of such therapy is misleading infectious disease serologic assays following administration of IVIG. The authors report a recent case in their neonatal intensive care unit of a 24-week gestational age girl with a misleading positive hepatitis C serology reaction following IVIG administration.
No takes yet. Share an insight, caveat, or question.
Nixon et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: